Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart

Florian Hofmann1, Larissa Fabritz, Juliane Stieber

  • 1Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Insights

Increased hyperpolarization-activated cyclic nucleotide-gated (HCN) channel activity in cardiac hypertrophy prolongs ventricular action potential repolarization, potentially increasing arrhythmia risk. This study links elevated I(f) to diminished repolarization reserve.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Electrophysiology

Background:

  • Cardiac hypertrophy alters gene expression, affecting ion channel function and increasing arrhythmia risk.
  • The role of the depolarizing current I(f) in hypertrophied ventricles remains unclear.

Purpose of the Study:

  • To investigate the contribution of I(f) to arrhythmogenesis in cardiac hypertrophy.
  • To elucidate the role of HCN channel isoforms in hypertrophic ventricular I(f).

Main Methods:

  • Ventricular hypertrophy was induced in mice using transverse aortic constriction.
  • Expression of HCN isoforms and I(f) current were analyzed in hypertrophied and control hearts.
  • Genetic deletion of HCN2 and HCN4 was performed to assess I(f) function.

Main Results:

  • Hypertrophy enhanced ventricular I(f) and increased I(f) positive myocytes.
  • HCN2 and HCN4 were the primary subunits, with HCN1 transcript upregulated.
  • Combined deletion of HCN2 and HCN4 abolished I(f) and attenuated pro-arrhythmogenic parameters.
  • Action potential prolongation and QT interval lengthening were reduced in hypertrophic double-knockouts.

Conclusions:

  • Increased HCN channel activity in hypertrophied myocytes may prolong ventricular action potential repolarization, elevating arrhythmia potential.
  • This study establishes a direct link between elevated ventricular I(f) and reduced repolarization reserve in cardiac hypertrophy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...